The Leukemia & Lymphoma Society (LLS) exists to find cures and ensure access to treatments for patients with blood cancer.

LLS is the world’s largest voluntary health agency dedicated to finding cures for leukemia, lymphoma, myeloma, and other blood cancers. To date, LLS has invested more than $1 billion in research to advance therapies and save lives. LLS research grants have funded many of today’s most promising advances, including targeted therapies and immunotherapies.

LLS is the leading source of free blood cancer information, education, and support for patients, survivors, families, and healthcare professionals. Its Information Resource Center provides the public, families, healthcare professionals, and people living with blood cancers with accurate, up-to-date, disease-related information and referral services. LLS’ services also include free teleconferences and educational webcasts, support groups, information on the latest clinical trials and treatments, and workshops that address survivorship issues.

LLS is the voice for all patients with blood cancer, touching patients and their families through its chapters across the United States and Canada. LLS advocates for policies at the federal and state levels to accelerate the approval of new treatments and ensure access to quality, affordable, and coordinated care.

For more information about LLS, please visit www.lls.org.

Information about this independent organization is provided as an additional resource for obtaining information related to multiple myeloma. It does not indicate endorsement by Celgene Corporation of an organization or its communications.

Your healthcare team is your best source of information.

Was this helpful?

Brought to you by Celgene Corporation. | Intended for a US audience.